• PEDV Hijacks IMPDH-Dependent Nucleotide Biosynthesis

  2026-08-08

  The reference study identifies IMPDH-dependent guanine nucleotide biosynthesis as a host pathway that porcine epidemic diarrhea virus (PEDV) requires for efficient replication. By combining comparative metabolomics, IMPDH2 knockdown, and pharmacological inhibition with Merimepodib (VX-497), the authors provide evidence for a host-directed antiviral vulnerability while also revealing cell-specific metabolic responses.

• Inflammation in Ischemic Stroke: Biomarkers to Treatment

  2026-08-07

  Xiao and colleagues’ 2025 review integrates inflammatory mechanisms, biomarkers, and treatment research in ischemic stroke into a single translational framework. Its practical value lies in linking the timing and compartmentalization of inflammation with diagnostic interpretation and therapeutic design, while emphasizing that biomarker-guided treatment remains context dependent.

• DiD (DiDC 18 (5)): Advanced Membrane Probing in Inflammation

  2026-08-07

  Explore how DiD (DiDC 18 (5)) enables precise cell membrane staining and tracking in complex inflammatory and high-ROS environments. This article reveals unique protocol insights and cross-disciplinary applications, offering a deeper scientific perspective on this red fluorescent probe.

• Hydrocortisone in Precision Model Systems: Pathways and Prot

  2026-08-06

  Explore how hydrocortisone, a core glucocorticoid hormone, enables precision modeling of anti-inflammatory and stress response pathways. This article reveals advanced applications, mechanistic insights, and assay decision guidance not covered elsewhere.

• Berberrubine Modulates Urate Transport and JAK2/STAT3 in Hyp

  2026-08-06

  This study demonstrates that berberrubine, a major berberine metabolite, effectively lowers serum uric acid and ameliorates kidney injury in a murine hyperuricemia model. Through regulation of urate transporters and suppression of the JAK2/STAT3 pathway, berberrubine provides mechanistic insight into inflammation control and urate handling, with implications for metabolic disease research.

• PAD4-IN-2 TFA: Targeting NETs for Precision Tumor Research

  2026-08-05

  PAD4-IN-2 TFA (Compound 5i TFA) leverages meta-phenylboronic acid modification for tumor-selective inhibition of PAD4, enabling researchers to dissect and modulate the tumor immune microenvironment with minimal toxicity. This guide translates cutting-edge findings into actionable workflows, troubleshooting tips, and comparative insights for advanced cancer research using APExBIO’s PAD4-IN-2 TFA.

• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-08-05

  This study reveals that certain kinase inhibitors, including Imatinib hydrochloride, can simultaneously inhibit p38α MAP kinase activity and enhance its dephosphorylation by stabilizing a phosphatase-accessible conformation. These findings provide a mechanistic basis for dual-action inhibitor design, suggesting new strategies for improving specificity and potency in kinase-targeted cancer research.

• Vitamin C (CAS 50-81-7): Cellular Senescence, ROS, and Cance

  2026-08-04

  Explore the scientifically validated roles of Vitamin C (ascorbic acid) in cellular senescence, ROS modulation, and cancer research. This article delivers new mechanistic insights beyond organoid models, providing experimental guidance for advanced biomedical workflows.

• SB 431542: Unlocking ALK5 Inhibition for Translational Disco

  2026-08-04

  This thought-leadership article explores the strategic deployment of SB 431542 as a selective ALK5 inhibitor, bridging mechanistic insight with actionable guidance for translational researchers. Drawing on recent breakthroughs in 3D organoid modeling and TGF-β pathway perturbation, we contextualize both the practical and visionary implications of precise Smad2 phosphorylation inhibition for developmental biology and anti-tumor immunology.

• FITC-Concanavalin A (ConA) Conjugate: Technical Lab Use Guid

  2026-08-03

  FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose on cell surfaces, supporting workflows in immunofluorescence, flow cytometry, and glycobiology. It is not suitable for non-carbohydrate-binding assays or protocols outside its defined stability and storage parameters. For optimal results, users must adhere closely to product specifications and established best practices.

• Technical Guidelines for TBST (Tris-Buffered Saline and Twee

  2026-08-03

  TBST (Tris-Buffered Saline and Tween 20) addresses nonspecific binding and high background in antibody-based assays, particularly Western blotting and immunohistochemistry. Its isotonic formulation with non-ionic detergent supports reproducibility in signal detection but should not be used where detergent sensitivity is a concern.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody: Next-Gen Signal Amp

  2026-08-02

  Explore how the HRP Rabbit Anti-Goat IgG (H+L) Antibody enables next-level sensitivity in immunodetection of goat primary antibodies. This article offers a unique, protocol-driven perspective on assay optimization and translational research impact.

• Biomimetic Chromatography Advances Pulmonary Permeability Mo

  2026-08-01

  The reference study introduces and rigorously evaluates biomimetic open tubular capillary electrochromatography (OT-CEC) and immobilised artificial membrane liquid chromatography (IAM-LC), both coupled with mass spectrometry, for modeling lung drug permeability. These MS-compatible techniques enable high-throughput, robust assessment of pharmaceutical absorption relevant to respiratory disease research and anti-inflammatory corticosteroid development.

• CFDA SE Cell Tracer Kit: Technical Guidance for Stable Cell

  2026-07-31

  The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit provides researchers with a robust, covalent fluorescent labeling method for long-term cell tracing in both in vitro and in vivo settings. It is suited for applications like cell lineage and proliferation studies where stable, persistent cell marking is required, but is not appropriate for workflows needing reversible or short-term cell labeling.

• Ruxolitinib Phosphate: Mitochondrial Dynamics and JAK/STAT M

  2026-07-31

  Explore the unique dual role of Ruxolitinib phosphate (INCB018424) in modulating JAK/STAT signaling and mitochondrial fission, with implications for cancer and autoimmune disease research. This article provides in-depth mechanistic insights and assay guidance for translational scientists.

8307 records 3/554 page Previous Next 12345 下5页 Last page